Assess Cell Cultures with Axio Vert.A1 from Carl Zeiss

All contrasting techniques with total flexibility

(PresseBox) (Jena, ) The Axio Vert.A1 is an inverted microscope from Carl Zeiss with extensive performance capabilities. For the first time, a compact cell culture microscope combines all standard contrasting techniques in a single stand.

In transmitted light, the Axio Vert.A1 offers brightfield, phase contrast, polarization contrast, PlasDIC, VAREL and improved Hoffmann modulation contrast (iHMC). The microscope is the only system in its class to also offer differential interference contrast (DIC). This makes it possible to record very fine structures in cells, enabling users to better assess cell cultures. The Axio Vert.A1 is excellently suited for use in reproductive medicine, particularly in in-vitro fertilization (IVF). The iHMC, PlasDIC and DIC contrasting techniques are integrated to allow observation of egg cells and sperm without any need to reconfigure the system. This protects the specimens and saves both time and effort.

In fluorescence applications, the Axio Vert.A1 uses long-life LED illumination. The entire image field is illuminated homogeneously; no alignment is necessary. As LED excitation light does not contain any undesired UV components, cell survival rate increases significantly.

The Axio Vert.A1 has been specially designed so that it can be positioned directly beside the incubator or the sterile bench. Adapters allow comfortable, upright work in either a seated or standing position. Due to the ergo tube, the eyepieces can be tilted to allow comfortable and convenient microscopy. This facilitates routine tasks and supports workflows in cases where urgency is of the essence.

Diese Pressemitteilungen könnten Sie auch interessieren

News abonnieren

Mit dem Aboservice der PresseBox, erhalten Sie tagesaktuell und zu einer gewünschten Zeit, relevante Presseinformationen aus Themengebieten, die für Sie interessant sind. Für die Zusendung der gewünschten Pressemeldungen, geben Sie bitte Ihre E-Mail-Adresse ein.

Es ist ein Fehler aufgetreten!

Vielen Dank! Sie erhalten in Kürze eine Bestätigungsemail.


Ich möchte die kostenlose Pressemail abonnieren und habe die Bedingungen hierzu gelesen und akzeptiert.